Verified Sponsor Execution & Regulatory Ledger
| Sponsor Metric | Verified Count / Rate |
|---|---|
| Phase II & III Protocols (2018 to 2026) | 123 |
| Active Pipeline (Recruiting Now) | 58 (39) |
| Completed vs Stopped Early | 28 / 35 (28.5%) |
| Median Closed Actual Enrollment | 20 participants |
| Physical Hospital Site Disclosure | 100.0% named hospitals |
| FDA Drugs@FDA Original NDA/BLA Approvals | 0 (0 since 2018) |
Top Partner U.S. Hospital Clinical Research Sites
| Hospital Research Site | Location | Shared Protocols |
|---|---|---|
| Fred Hutch/University of Washington Cancer Consortium | Seattle, WA | 76 |
| University of Washington | Seattle, WA | 13 |
| Fred Hutchinson Cancer Center and UW Medicine | Seattle, WA | 8 |
Explore interactive annual charts and M&A subsidiary rollups in the University of Washington Interactive Dossier, benchmark peers in Oncology and Hematology, or review the Healthcare Price & Patent Cliff Crosswalk.